BBS-Bioactive Bone Substitutes Oyj (BONEH) - Total Liabilities

Latest as of June 2024: €5.58 Million EUR ≈ $6.52 Million USD

Based on the latest financial reports, BBS-Bioactive Bone Substitutes Oyj (BONEH) has total liabilities worth €5.58 Million EUR (≈ $6.52 Million USD) as of June 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See BONEH days of operational coverage to measure how many days the company can operate on defensive assets alone.

BBS-Bioactive Bone Substitutes Oyj - Total Liabilities Trend (2014–2023)

This chart illustrates how BBS-Bioactive Bone Substitutes Oyj's total liabilities have evolved over time, based on quarterly financial data. Check BONEH cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

BBS-Bioactive Bone Substitutes Oyj Competitors by Total Liabilities

The table below lists competitors of BBS-Bioactive Bone Substitutes Oyj ranked by their total liabilities.

Company	Country	Total Liabilities
BELGRAVIA HARTFORD CAP. F:ECA	Germany	€2.63 Million
Next Biometrics Group ASA OL:NEXT	Norway	Nkr28.44 Million
INCUVO S.A. ZY -50 F:68X	Germany	€2.42 Million
Avidian Gold Corp V:AVG	Canada	CA$73.14K
Impax Asset Management Group Plc LSE:IPX	UK	GBX39.48 Million
WILDCAT PRETR.LS -000028 F:8Y6	Germany	€54.00K
Heritage Distilling Holding Company, Inc. NASDAQ:IPST	USA	$10.36 Million
ILYA Co. Ltd KQ:058450	Korea	₩18.36 Billion

Liability Composition Analysis (2014–2023)

This chart breaks down BBS-Bioactive Bone Substitutes Oyj's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see BONEH total assets.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	0.39	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.47	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.60	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how BBS-Bioactive Bone Substitutes Oyj's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for BBS-Bioactive Bone Substitutes Oyj (2014–2023)

The table below shows the annual total liabilities of BBS-Bioactive Bone Substitutes Oyj from 2014 to 2023.

Year	Total Liabilities	Change
2023-12-31	€5.50 Million ≈ $6.44 Million	-14.21%
2022-12-31	€6.42 Million ≈ $7.50 Million	-6.63%
2021-12-31	€6.87 Million ≈ $8.03 Million	+4.04%
2020-12-31	€6.61 Million ≈ $7.72 Million	-2.19%
2019-12-31	€6.75 Million ≈ $7.90 Million	+0.21%
2018-12-31	€6.74 Million ≈ $7.88 Million	-21.63%
2017-12-31	€8.60 Million ≈ $10.05 Million	+4.80%
2016-12-31	€8.21 Million ≈ $9.59 Million	+2.70%
2015-12-31	€7.99 Million ≈ $9.34 Million	+9.60%
2014-12-31	€7.29 Million ≈ $8.52 Million	--

About BBS-Bioactive Bone Substitutes Oyj

HE:BONEH Finland Medical Devices

Market Cap

$1.76 Million

€1.50 Million EUR

Market Cap Rank

#30401 Global

#150 in Finland

Share Price

€0.05

Change (1 day)

+0.00%

52-Week Range

€0.05 - €0.05

All Time High

€9.68